Journal of the Chemical Society - Faraday Transactions p. 1015 - 1022 (1994)
Update date:2022-08-24
Topics:
Aas, Nina
Pringle, Thomas J.
Bowker, Michael
The adsorptive and reactive behaviour of TiO2, SrTiO3 and SrO towards methanol have been investigated using temperature-programmed desorption and XPS.TiO2 was found to be reduced during the adsorption/desorption process and showed predominantly CH4 formation at low coverages.At higher coverages, alternative paths led also to the desorption of CH3OH and HCHO though CH4 was the main product desorbed at ca. 500 K.The product pattern indicates that a methoxy is the major surface intermediate.CO and H2 were evolved at ca. 600 K, possibly from the decomposition of a formate species, while H2O was desorbed between 300 and 700 K.On SrO the coincident evolution of CO and H2 at 580 K, with H2O and CO2 being minor products, indicated a formate intermediate as the dominant one on this surface.The product pattern on SrTiO3 resembled that on TiO2, although the main product in this case was CH3OH, with CH4 being produced in much smaller quantities and only at much higher temperature than on TiO2 (620 K).The source of these differences is discussed in terms of the detect chemistry of the surface involved.
Nantong Auxin Electronic Technology Co., LTD
Contact:86-513-88760026
Address:NO.5-1, Aoxin Road, Haian Hi-tech Development Zone, Jiangsu Province, China
Contact:+86-20-32051076
Address:1105,Building A, International Business Incubator,Science City
Yancheng Smiling Imp & Exp Co., Ltd.
Contact:+86-515-83173586
Address:Rm1207, BLD#03, Phoenix Plaza, Juheng Road, Yancheng, Jiangsu, P.R. China
Zibo Fuxi'er Chemical Co.,Ltd （Shanxian Fuxi'er Chemical Co.,Ltd）
Contact:+86-533-2091422
Address:Eastern 4 on the 3th Road ,Liangxiang Industrial Park, Zibo city ,Shandong,China
Contact:13120882795；+86-21-34621078;+86-021-31122318
Address:Suite 2,No.2715 Longwu Road
Doi:10.1016/j.phytol.2016.08.005
(2016)Doi:10.1016/j.molcata.2014.06.041
(2014)Doi:10.1016/S0022-1139(00)82059-X
(1987)Doi:10.1002/adsc.200404195
(2004)Doi:10.1021/ol0362919
(2004)Doi:10.1016/j.ijpharm.2014.04.007
(2014)
